11th EGA Legal Affairs Forum 26 - 27 March 2015 Thon Hotel EU Rue de la Loi/Wetstraat 75 – 1040 Brussels, Belgium Thursday 26 March 2015 11th EGA Legal Affairs Forum 13:00 Registrations & Welcome buffet lunch 14:00 Welcome by Nick Haggar, President, EGA (TBC) 14:10 Session I - “EGA 2020” - where are the latest trends leading this sector? A panel Discussion with EGA Members’ Senior Lawyers Chair Adrian van den Hoven, Director General, EGA Panel discussion with Shannon Klinger, Global Head Legal and General Counsel, Sandoz Suzanne Smith, Executive Director, Legal, Actavis Falk Nuernberger, General Counsel Europe, Mylan Panelists TBC 15:10 Questions & answers 15:20 Coffee break 15:50 Session II - A Supplementary Protection Certificate (SPC) export exception: the way forward? Chair Julia Pike, Head Global IP Litigation, Sandoz Speaker Alexander Wittkopp, Partner, Maiwald Panel discussion with François Arbault, Heads of unit DG MARKT, European Commission Thomas Kolzau, Patent Affairs, Helm Panellists TBC 16:50 Questions & answers 17:00 End-of-day cocktail EUROPEAN GENERIC MEDICINES ASSOCIATION AISBL (EGA) Rue d’Arlon 50, B-1000 Brussels, Belgium T: +32-(0)2-736 8411 F: +32-(0)2-736 7438 E: [email protected] www.egagenerics.com VAT: BE 0449 332 209 11th EGA Legal Affairs Forum Friday 27 March 2015 08:00 Networking coffee Session III - The interplay between IP and regulatory matters Chair György Thaler, Chair Legal Affairs Committee, EGA 09:00 Second medical use and dose regimen claims Fiona Bor, Director of Intellectual Property, Mylan and Duncan Curley, Founder & Head of Patents, Innovate Legal 09:20 Orphan drugs exclusivities Speaker TBC 09:40 Sunset clause Javier Huarte, Partner, Grau & Angulo, Spain 10.00 Euro-Bolar situation Christoph de Coster, Taylor Wessing (TBC) 10:20 EMA policy on Clinical Trial Transparency Trevor Cook, Partner, WilmerHale 10:40 Coffee break 11:10 Panel debate Stefano Marino, Head of Legal Department, EMA Javier Huarte, Partner, Grau & Angulo, Spain Ravinder Chahil, Director of Intellectual Property, Polpharma Panellists TBC 12:00 Questions & answers 12:15 Networking Buffet Lunch Session IV - The latest trends in patent litigations globally and in the EU – How is the European industry affected? Chair Ravinder Chahil, Director of Intellectual Property, Polpharma 13:30 General update on court cases that impact the industry Speaker TBC 13:50 Questions & answers 14:00 Presumption of patent validity in patent litigations – the new trends Kristof Roox, Partner, Crowell & Moring 14:20 Questions & answers 14:30 The global impact of the changes in the US Patent Guidance: Post Myriad v Prometheus decision: New rulings for patentability under 35 U.S.C. §101 Albin J. Nelson, Ph.D., J.D., Senior Shareholder SLWIP EUROPEAN GENERIC MEDICINES ASSOCIATION AISBL (EGA) Rue d’Arlon 50, B-1000 Brussels, Belgium T: +32-(0)2-736 8411 F: +32-(0)2-736 7438 E: [email protected] www.egagenerics.com VAT: BE 0449 332 209 14:50 Questions & answers 15:00 Biosimilars patent litigation Speaker TBC 15:20 Questions & answers 15:30 End of Forum Coffee For further information and to register on-line, please visit: www.egaevents.org/laf or www.egagenerics.com Lucia Romagnoli - T: +44-7562-876873 - E: [email protected] Registrations close officially on 18 March 2015 and are subject to availability. EUROPEAN GENERIC MEDICINES ASSOCIATION AISBL (EGA) Rue d’Arlon 50, B-1000 Brussels, Belgium T: +32-(0)2-736 8411 F: +32-(0)2-736 7438 E: [email protected] www.egagenerics.com VAT: BE 0449 332 209
© Copyright 2024